Coronavirus SARS-CoV1 infection (SARS)

Essential Evidence

Last Updated on 2021-03-10 © 2021 John Wiley & Sons, Inc.

Printer Friendly

Authors:
M. Joyce Green, MD, Assistant Professor, Penn State Health Hershey Medical Center
Pete Yunyongying, MD, FACP, Associate Professor , Carle-Illinois College of Medicine, University of Illinois
Mark H. Ebell, MD, MS, Professor, College of Public Health, University of Georgia
Mindy A. Smith, MD, MS, Clinical Professor, Department of Family Medicine, Michigan State University

Editor:
Mark H. Ebell, MD, MS, Professor, College of Public Health, University of Georgia

Overall Bottom Line

  • The most common presenting symptoms of the SARS-CoV1 in 2003 were fever, chills, myalgia, malaise, and cough. 1 Test patients for SARS-CoV1 using PCR only if no other cause of pneumonia can be found 72 hours after starting a workup and if the patient has risk factors for SARS-CoV1. Consult public health authorities prior to testing. G5C
  • Supportive care is the mainstay of treatment. Although most patients were treated with corticosteroids and antivirals, there is little evidence that these interventions improved outcomes, and they are known to have ill effects. C 2
  • The case fatality ratio in over 8000 cases reported by the WHO in 2003 was 9.6%. G18C
  • A separate chapter address infection with SARS-CoV2 and COVID-19.

Search PubMed with advanced filtering
for the best evidence..

Related Evidence

Clinical Rules

POEMs

General Treatment

Drug Treatment

Surgery, anesthesia, and procedures

Harm

History and Physical

Diagnostic Tests

Miscellaneous Diagnosis

Prevention (primary)

Prognosis of disease / natural history

Causation and etiology

Incidence and prevalence of disease

Risk factors for disease

Practice Administration/Health Systems

Medical Education

Practice guidelines

Cochrane